Found: 3
Select item for more details and to access through your institution.
Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 1, p. 57, doi. 10.1007/s00432-021-03874-2
- By:
- Publication type:
- Article
Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.
- Published in:
- Cellular Oncology (2211-3428), 2020, v. 43, n. 1, p. 81, doi. 10.1007/s13402-019-00473-9
- By:
- Publication type:
- Article
The ERBB receptor inhibitor dacomitinib suppresses proliferation and invasion of pancreatic ductal adenocarcinoma cells.
- Published in:
- Cellular Oncology (2211-3428), 2019, v. 42, n. 4, p. 491, doi. 10.1007/s13402-019-00448-w
- By:
- Publication type:
- Article